(E)-1-(2-aminophenyl)-3-phenylprop-2-en-1-ones: synthesis and structure of new polymorph
Închide
Articolul precedent
Articolul urmator
645 4
Ultima descărcare din IBN:
2021-04-22 04:31
Căutarea după subiecte
similare conform CZU
538.9+546+548.3 (1)
Fizica materiei condensate. Fizica solidului (349)
Chimie anorganică (450)
Cristalografie (54)
SM ISO690:2012
BOUROSH, Pavlina, KRAVTSOV, Victor, BACHINSKII, Sergey, PAVLOVSKY, Victor, ANDRONATI, Sergei. (E)-1-(2-aminophenyl)-3-phenylprop-2-en-1-ones: synthesis and structure of new polymorph. In: Materials Science and Condensed Matter Physics, Ed. 9, 25-28 septembrie 2018, Chișinău. Chișinău, Republica Moldova: Institutul de Fizică Aplicată, 2018, Ediția 9, p. 152.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Materials Science and Condensed Matter Physics
Ediția 9, 2018
Conferința "International Conference on Materials Science and Condensed Matter Physics"
9, Chișinău, Moldova, 25-28 septembrie 2018

(E)-1-(2-aminophenyl)-3-phenylprop-2-en-1-ones: synthesis and structure of new polymorph

CZU: 538.9+546+548.3

Pag. 152-152

Bourosh Pavlina1, Kravtsov Victor1, Bachinskii Sergey2, Pavlovsky Victor2, Andronati Sergei2
 
1 Institute of Applied Physics,
2 A.V. Bogatsky Physico-Chemical Institute of the NAS of Ukraine
 
Proiecte:
 
Disponibil în IBN: 5 februarie 2019


Rezumat

1,3-Diphenyl-2-propen-1-ones show antimicrobial, antifungal, antitumor, antioxidant, cytotoxic, antiproliferative, anti-inflammatory, hepatoprotective and other types of activities. They also serve as precursors for the synthesis of a number of biologically active compounds. Condensation of 2- aminoacetophenone with aromatic aldehydes yielded a series of (E)-1-(2-aminophenyl)-3- phenylprop-2-en-1-ones. The structure of compounds 2-7 was confirmed by mass spectrometry and 1H-NMR spectroscopy, and for (E)-1-(2-aminophenyl)-3-(4-chlorophenyl)prop-2-en-1-one 5 also by the single crystal X-ray diffraction.  NH2 O R NH2 O CH3 Ar O EtOH, KOH 1 R = H (2), OCH3 (3), F (4), Cl (5), Br (6), NO2 (7) 2 - 7  The compound 5 crystallizes in the monoclinic P21/c space group, a=8.459(2), b=6.729(1), c=21.996(3) Å; β=106.429(5)o, V=1249.7(4)Å3, Z=4 with one molecule per asymmetric unit (Z‘=1) in contrast to the recently published orthorhombic polymorph (sp.gr. P212121, Z=8, Z‘=2) [1]. The molecule is planar within 0.18Å. The C-C bond distances adjust the common values, the C=O1, C-N1, and C-Cl1 bond distances are equal to 1.234(4), 1.355(5) and 1.733(3) Å, respectively. The C=C double bond is equal to 1.307(4) Å. The conformation of the molecule is stabilized by intramolecular N-H…O = 2.627Å hydrogen bond. In the crystal the neighboring center-symmetry related molecules reside in parallel planes with interplanar separation 3.446 Å and are coupled due to arene–alkene π-stacking interactions [2]. The distances from the centroid of the aromatic ring to the midpoint of the C=C double bond equals 3.484 Å. Such dimeric associates further interact via C-H…O = 3.392 Å bonds resulting in formation of ribbon along crystallographic axis b.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-71597</cfResPublId>
<cfResPublDate>2018</cfResPublDate>
<cfVol>Ediția 9</cfVol>
<cfStartPage>152</cfStartPage>
<cfISBN></cfISBN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/71597</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>(E)-1-(2-aminophenyl)-3-phenylprop-2-en-1-ones: synthesis and structure of new polymorph</cfTitle>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>1,3-Diphenyl-2-propen-1-ones show antimicrobial, antifungal, antitumor, antioxidant, cytotoxic, antiproliferative, anti-inflammatory, hepatoprotective and other types of activities. They also serve as precursors for the synthesis of a number of biologically active compounds. Condensation of 2- aminoacetophenone with aromatic aldehydes yielded a series of (E)-1-(2-aminophenyl)-3- phenylprop-2-en-1-ones. The structure of compounds <strong>2</strong>-<strong>7 </strong>was confirmed by mass spectrometry and 1H-NMR spectroscopy, and for (E)-1-(2-aminophenyl)-3-(4-chlorophenyl)prop-2-en-1-one <strong>5 </strong>also by the single crystal X-ray diffraction. &nbsp;NH2 O R NH2 O CH3 Ar O EtOH, KOH 1 R = H (2), OCH3 (3), F (4), Cl (5), Br (6), NO2 (7) 2 - 7 &nbsp;The compound <strong>5 </strong>crystallizes in the monoclinic <em>P</em>21/<em>c </em>space group, <em>a</em>=8.459(2), <em>b</em>=6.729(1), <em>c</em>=21.996(3) &Aring;; <strong><em>&beta;</em></strong>=106.429(5)<sup>o</sup>, <em>V</em>=1249.7(4)&Aring;3, Z=4 with one molecule per asymmetric unit (Z&lsquo;=1) in contrast to the recently published orthorhombic polymorph (sp.gr. <em>P</em>212121, Z=8, Z&lsquo;=2) [1]. The molecule is planar within 0.18&Aring;. The C-C bond distances adjust the common values, the C=O1, C-N1, and C-Cl1 bond distances are equal to 1.234(4), 1.355(5) and 1.733(3) &Aring;, respectively. The C=C double bond is equal to 1.307(4) &Aring;. The conformation of the molecule is stabilized by intramolecular N-H&hellip;O = 2.627&Aring; hydrogen bond. In the crystal the neighboring center-symmetry related molecules reside in parallel planes with interplanar separation 3.446 &Aring; and are coupled due to arene&ndash;alkene &pi;-stacking interactions [2]. The distances from the centroid of the aromatic ring to the midpoint of the C=C double bond equals 3.484 &Aring;. Such dimeric associates further interact via C-H&hellip;O = 3.392 &Aring; bonds resulting in formation of ribbon along crystallographic axis <em>b</em>.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-197</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-1035</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-58789</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-54360</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13834</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-197</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-197-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
<cfFamilyNames>Bourosh</cfFamilyNames>
<cfFirstNames>Pavlina</cfFirstNames>
<cfFamilyNames>Боурош</cfFamilyNames>
<cfFirstNames>Павлина</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-1035</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-1035-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
<cfFamilyNames>Kravtsov</cfFamilyNames>
<cfFirstNames>Victor</cfFirstNames>
<cfFamilyNames>Кравцов</cfFamilyNames>
<cfFirstNames>Виктор</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-58789</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-58789-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
<cfFamilyNames>Bachinskii</cfFamilyNames>
<cfFirstNames>Sergey</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-54360</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-54360-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
<cfFamilyNames>Pavlovsky</cfFamilyNames>
<cfFirstNames>Victor</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13834</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13834-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2018T24:00:00</cfStartDate>
<cfFamilyNames>Andronati</cfFamilyNames>
<cfFirstNames>Sergei</cfFirstNames>
<cfFamilyNames>Андронати</cfFamilyNames>
<cfFirstNames>Сергей</cfFirstNames>
<cfFamilyNames>Андронаті</cfFamilyNames>
<cfFirstNames>С.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>